Inhalation of Low Molecular Weight Heparins as Prophylaxis against SARS-CoV-2

Inhalation of Low Molecular Weight Heparins as Prophylaxis against SARS-CoV-2

ABSTRACT New SARS-CoV-2 variants of concern and waning immunity demonstrate the need for a quick and simple prophylactic agent to prevent infection. Low molecular weight heparins (LMWH) are potent inhibitors of SARS-CoV-2 binding and infection in vitro. The airways are a major route for infection an...

Full description

Bibliographic Details
Main Authors: Julia Eder, Marta Bermejo-Jambrina, Killian E. Vlaming, Tanja M. Kaptein, Viktoria Zaderer, E. Marleen Kemper, Doris Wilflingseder, Sietze Reitsma, Godelieve J. de Bree, Danny M. Cohn, Teunis B. H. Geijtenbeek
Format: Article
Language:English
Published: American Society for Microbiology 2022-12-01
Series:mBio
Subjects:
low molecular weight heparin
SARS-CoV-2
infection prevention
virus-host interactions
Online Access:https://journals.asm.org/doi/10.1128/mbio.02558-22

Internet

https://journals.asm.org/doi/10.1128/mbio.02558-22

Similar Items